SHARE THIS LINKEDIN English Français Deutsch EUDRAC European Drug Regulatory Affairs Consulting UK +44 (0)1865 893274 FR +33 (0) 4 30 00 50 50 DE +49 (0)6221 755220 HOME SERVICES NEWS VACANCIES ABOUT US CONTACT US Drug Development and Strategy Marketing Authorisation Applications Post-approval Pharmacovigilance Publishing What else? We can help you in the optimal strategy and development of your product. We can help you in your European MAA by offering a full range of services. Let our experienced team reduce the strain on you. We understand the importance of the pharmacovigilance requirements for your product. We know how important submission deadlines are. We can work with you on all types of regulatory activities to achieve your objectives. Welcome to the EUDRAC website We are a specialised regulatory affairs consultancy company providing support to drive products through development, registration, market launch and post-approval activities across all EU countries. We take pride in understanding your needs and customising our service to your company’s or product’s needs. Our philosophy is “Quality for Success”. Please click on the buttons above for more information on the services we provide. Let us help you to achieve your goals! BROCHURE LATEST NEWS 1st Oct 2015 Sitagliptin Tablets: 1st Finished Product Monograph of the European Pharmacopoeia 17th Sep 2015 Join EUDRAC at CPhI Worldwide in Madrid on 13 – 15 October 2015 9th Sep 2015 Updated guidance on good clinical practice now available for comments! Up Down “In over 30 years of out-sourcing on behalf of large and small pharmaceutical companies, the range of regulatory services provided by Eudrac has never been bettered. They have provided not only great insight into the EU regulatory processes but offered highly professional input into the design and content of regulatory documents and dossiers. They have been able invariably to offer customised packages to fit the skills needs of the clients and have consistently become integral members, or often leaders, of the project management teams.” Dr Mike Wyllie, CSO Plethora Solutions plc and non-executive board member of Repros (NASDAQ) © EUDRAC Privacy Legal Site map